Log In
Monday 21st May 2018

Drug sector must change

14th June 2007

A new report into the pharmaceutical industry has warned that companies need to shift more investment into research and link their drug prices more tightly to efficacy.

Consultancy firm PwC argues in its document “Pharma 2020: the vision� that the current pharmaceutical industry business model is economically unsustainable and “operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets.�

PwC stress that improving research and development productivity is the most important challenge, but points out that research and development by leading companies has only risen from 15% to 17.1% in a decade.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018